Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS

The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. As no vaccine or drugs are currently approved to specifically treat COVID-19, identification of effective therapeutics is crucial to treat the afflicted...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Res Sq
Главные авторы: O’Donovan, Sinead M, Eby, Hunter, Henkel, Nicholas D, Creeden, Justin, Imami, Ali, Asah, Sophie, Zhang, Xiaolu, Wu, Xiaojun, Alnafisah, Rawan, Taylor, R. Travis, Reigle, James, Thorman, Alexander, Shamsaei, Behrouz, Meller, Jarek, McCullumsmith, Robert E
Формат: Artigo
Язык:Inglês
Опубликовано: American Journal Experts 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336712/
https://ncbi.nlm.nih.gov/pubmed/32702077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-25643/v1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы